Cargando…

The utilization of atrial sensing dipole in single lead implantable cardioverter defibrillator for detection of new‐onset atrial high‐rate episodes or subclinical atrial fibrillation: A systematic review and meta‐analysis

This meta‐analysis aims to evaluate the performance of atrial sensing dipole in single lead implantable cardioverter defibrillator (VDD‐ICD) recipients in particular diagnosing new‐onset atrial high‐rate episodes (AHREs) defined as rate threshold of 200 beats per minute, or subclinical atrial fibril...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pung, Xuanming, Hong, Daniel Zhihao, Ho, Tzyy Yeou, Shen, Xiayan, Tan, Pei Ting, Yeo, Colin, Tan, Vern Hsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Clinical Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977580/ https://www.ncbi.nlm.nih.gov/pubmed/35387136 http://dx.doi.org/10.1002/joa3.12675

Ejemplares similares

Subclinical atrial fibrillation detection with a floating atrial sensing dipole in single lead implantable cardioverter‐defibrillator systems: Results of the SENSE trial
por: Thomas, George, et al.
Publicado: (2019)

Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole
por: Hindricks, Gerhard, et al.
Publicado: (2023)

Induced atrial fibrillation during defibrillation test on implantation of subcutaneous implantable cardioverter defibrillator
por: Kim, Ki-Hun, et al.
Publicado: (2020)

Validation of MyDiagnostick tool to identify atrial fibrillation in a multi-ethnic Asian population
por: Yeo, Colin, et al.
Publicado: (2022)

Low efficacy of cardioversion of persistent atrial fibrillation with the implantable cardioverter-defibrillator
por: Limantoro, I., et al.
Publicado: (2013)

Omnipolar activation EGM to identify the earliest breakout site of atrial tachycardia
por: Yeo, Colin, et al.
Publicado: (2022)

Dual‐chamber implantable cardioverter–defibrillator. Is it useful in patient with permanent atrial fibrillation?
por: Porres‐Aracama, José M., et al.
Publicado: (2016)

A meta-analysis of extended ECG monitoring in detection of atrial fibrillation in patients with cryptogenic stroke
por: Jiang, Haowen, et al.
Publicado: (2022)

Implantation of single lead cardioverter defibrillator with floating atrial sensing dipole in a pregnant patient without using fluoroscopy
por: Quartieri, Fabio, et al.
Publicado: (2016)

Use of wearable cardioverter‐defibrillator in association with catheter ablation for atrial fibrillation‐related tachycardiomyopathy
por: Conti, Sergio, et al.
Publicado: (2019)

Cardiac Magnetic Resonance Imaging–Derived Left Atrial Characteristics in Relation to Atrial Fibrillation Detection in Patients With an Implantable Cardioverter‐Defibrillator
por: Hopman, Luuk H. G. A., et al.
Publicado: (2023)

Implantable Cardioverter-Defibrillator Implantation in a Patient with Atrial Standstill
por: Park, So Ra, et al.
Publicado: (2009)

Atrial pacing–induced oversensing in subcutaneous implantable cardioverter-defibrillator
por: Wharmby, Amy, et al.
Publicado: (2023)

Internal cardioversion of persistent atrial fibrillation in implantable cardioverter defibrillator patients: the juice is not worth the squeeze
por: Berger, W. R., et al.
Publicado: (2013)

Diagnosis of atrial fibrillation in heart failure patients with implantable cardioverter defibrillator or cardiac resynchronisation therapy
por: Dominik, Barbara, et al.
Publicado: (2021)

Atrial High-Rate Episodes, Subclinical Atrial Fibrillation and Short-Duration Clinical Atrial Fibrillation: Different Names for the Same Arrhythmia or a New Player On the Pitch?
por: Benezet-Mazuecos, Juan, et al.
Publicado: (2020)

Atrial fibrillation mimicking ventricular fibrillation confuses an automated external defibrillator
por: Hulleman, M., et al.
Publicado: (2018)

Oversensing of atrial fibrillatory waves in a subcutaneous implantable cardioverter-defibrillator
por: Karnik, Ankur A., et al.
Publicado: (2017)

Atrial signal amplitude predicts atrial high‐rate episodes in implantable cardioverter defibrillator patients: Insights from a large database of remote monitoring transmissions
por: Zecchin, Massimo, et al.
Publicado: (2020)

Catheter ablation for atrial fibrillation in a low-volume center using contemporary technology
por: Tay, Julian Cheong Kiat, et al.
Publicado: (2020)

How should I treat patients with subclinical atrial fibrillation and atrial high-rate episodes? Current evidence and clinical importance
por: Kreimer, Fabienne, et al.
Publicado: (2022)

Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?
por: Khan, Ahsan A., et al.
Publicado: (2019)

Subclinical atrial fibrillation: when to give NAO?
por: Patti, Giuseppe, et al.
Publicado: (2020)

Challenges in the Management of Atrial Fibrillation With Subclinical Hyperthyroidism
por: Gencer, Baris, et al.
Publicado: (2022)

Fragmented QRS and prediction of paroxysmal atrial fibrillation episodes
por: Temiz, Ahmet, et al.
Publicado: (2014)

Atrial fibrillation deteriorates tricuspid regurgitation following implantable cardioverter defibrillator lead placement in patient with hypertrophic obstructive cardiomyopathy
por: Mohri, Takato, et al.
Publicado: (2017)

Atrial Fibrillation Is Associated With Higher Overall Mortality in Patients With Implantable Cardioverter‐Defibrillator: A Systematic Review and Meta‐Analysis
por: Mustafa, Usman, et al.
Publicado: (2018)

Subclinical persistent atrial fibrillation in left atrium behind the ectopic atrial rhythm on electrocardiogram
por: Mizutani, Yoshiaki, et al.
Publicado: (2023)

Relationship between device‐detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator
por: Arai, Shuhei, et al.
Publicado: (2020)

Utility of directional high‐density mapping catheter (Advisor(TM) HD Grid) in complex scar‐related atrial tachycardia
por: Tan, Vern Hsen, et al.
Publicado: (2019)

Silent atrial fibrillation in patients with an implantable cardioverter defibrillator and coronary artery disease (INDICO AF) trial: study rationale and design
por: Baalman, S. W. E., et al.
Publicado: (2018)

Subclinical postoperative atrial fibrillation: a randomized trial
por: Sabbag, Avi, et al.
Publicado: (2023)

"Atrial torsades de pointes" Induced by Low-Energy Shock From Implantable-Cardioverter Defibrillator
por: Can, Ilknur, et al.
Publicado: (2013)

Cardiac resynchronization therapy defibrillators in patients with permanent atrial fibrillation
por: Rapacciuolo, Antonio, et al.
Publicado: (2021)

Increased left atrial pressure in non-heart failure patients with subclinical hypothyroidism and atrial fibrillation
por: Sairaku, Akinori, et al.
Publicado: (2016)

Distinct atrial remodeling in patients with subclinical atrial fibrillation: Lessons from computed tomographic images
por: Huang, Sung‐Hao, et al.
Publicado: (2022)

Left atrial appendage strain predicts subclinical atrial fibrillation in embolic strokes of undetermined source
por: Saberniak, Jørg, et al.
Publicado: (2023)

Atrial electrogram quality in single-pass defibrillator leads with floating atrial bipole in patients with permanent atrial fibrillation and cardiac resynchronization therapy
por: Sticherling, Christian, et al.
Publicado: (2018)

Does subclinical atrial fibrillation independently predict adverse outcomes in patients with heart failure and cardiac resynchronization therapy defibrillator
por: Chen, Jie, et al.
Publicado: (2021)

Lead dislodgement complicated with paroxysmal atrial fibrillation as a rare cause of inappropriate implantable cardioverter defibrillator shock: a case report
por: LIN, Gao-Feng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8g2ej5vlm99ahfplidvlg9g4h7